CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 136 filers reported holding CASTLE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $210,492 | -85.6% | 15,342 | -76.2% | 0.03% | -86.0% |
| Q1 2023 | $1,464,804 | +7.6% | 64,472 | +11.5% | 0.21% | +1.5% |
| Q4 2022 | $1,360,894 | -7.9% | 57,812 | +2.1% | 0.20% | -19.7% |
| Q3 2022 | $1,477,000 | +27.7% | 56,639 | +7.4% | 0.25% | +17.6% |
| Q2 2022 | $1,157,000 | -35.9% | 52,714 | +31.1% | 0.22% | -27.3% |
| Q1 2022 | $1,804,000 | +11.3% | 40,223 | +6.4% | 0.30% | +9.2% |
| Q4 2021 | $1,621,000 | +154.9% | 37,809 | +295.4% | 0.27% | +136.5% |
| Q3 2021 | $636,000 | -9.4% | 9,562 | -0.2% | 0.12% | -7.3% |
| Q2 2021 | $702,000 | – | 9,577 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |